CD133+ CRC cells manifested the CSC-like properties, such as higher levels of SC markers OCT4 and SOX2, tumor sphere forming ability, and more tumorigenic in NOD/SCID mice [82], which is consistent with OCT4 and SOX2 overexpression in poorly differentiated human tumors [83]. The gene discussed is PROM1; the disease is neoplasm.